ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms.

LightForce Orthodontics offers a fully personalized 3D printed braces system and digital treatment planning software. The Company is revolutionizing the orthodontic specialty through advanced manufacturing and technology. LightForce launched its first product to the orthodontic community in 2019 and now offers the only fully custom 7-to-7 braces system.

Ceribell is a medical device and artificial intelligence data analytics platform that deploys a cloud-linked, portable electroencephalogram (“EEG”) headband to facilitate rapid point-of-care diagnosis and treatment of life threatening neurological conditions.

Mission Bio is a life science tools company focused on single cell genomics, proteomics and multi-omics solutions for oncology study and cell and gene therapy development.

Aerin Medical is medical technology company focused on the ear, nose and throat market providing non-invasive solutions for the treatment of chronic nasal conditions.

BenevolentAI is a clinical-stage drug discovery company seeking to combine artificial intelligence and machine learning with science to decipher complex disease biology, generate new insights and discover more effective medicines. The company’s computational R&D platform spans each step of the drug discovery process, with a focus on novel disease targets discovery.

Pulmonx focuses on minimally invasive treatments for severe lung disease. The company’s platforms are designed to assess and treat patients with severe emphysema and chronic obstructive pulmonary disease who, despite medical management, are still symptomatic. Pulmonx completed its IPO on the Nasdaq stock market in October 2020.

Arbor Biotechnologies is a biotechnology company that aims to discover and develop the next generation of genetic medicines based on wholly owned genomic editors discovered from its machine learning/AI driven discovery platform.

Endeavor BioMedicines is a clinical-stage precision medicine company that targets the core drivers of multiple terminal diseases, including oncology and fibrosis. The Company seeks to combine advancements in technology with an evolving understanding of terminal diseases in order to develop best-in-class medicines with the potential to reverse the most severe health conditions.

Shoreline Biosciences is a biotechnology company developing genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer and macrophage immunotherapies for the treatment of cancer.